Iopamiro 200

Iopamidol, the active ingredient in Iopamiro 200, is a iodinated contrast agent presented as a 200 mg I/mL injection solution for intravenous use. It provides radiopaque contrast for diagnostic imaging procedures and is employed in patients undergoing computed tomography, angiography, urography, myelography and other studies that require enhanced visualization of vascular and tissue structures.

GNH USA supplies Iopamiro 200 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iopamiro 200, an iodinated contrast agent, is used in radiographic procedures that require enhanced X‑ray attenuation.

Contrast‑enhanced computed tomography (CT): improves delineation of organs and lesions during CT scans. Angiography: provides clear visualization of blood vessels for diagnostic and interventional procedures. Urography: enhances imaging of the urinary tract to detect obstructions or stones. Myelography: facilitates detailed imaging of the spinal canal and nerve roots.

Iopamiro 200 may be associated with adverse reactions following intravenous administration.

Common Side Effects: - Warm sensation or flushing: transient feeling of heat at the injection site. - Nausea: mild to moderate upset stomach. - Headache: mild headache during or after the procedure. - Metallic taste: temporary alteration of taste perception.

Serious or Rare Side Effects: - Allergic reaction: urticaria, bronchospasm, or anaphylaxis requiring immediate treatment. - Contrast‑induced nephropathy: acute kidney injury, especially in patients with pre‑existing renal impairment. - Cardiovascular collapse: hypotension or arrhythmia in rare cases.

Prior to using Iopamiro 200, clinicians should consider several safety precautions. - Renal function assessment: evaluate serum creatinine and eGFR before administration. - Allergy history: screen for prior reactions to iodinated contrast or iodine‑containing products. - Hydration status: ensure adequate patient hydration to reduce risk of nephropathy. - Thyroid disease: monitor patients with hyper‑ or hypothyroidism due to iodine load. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep below 25 °C, protect from light and moisture, and retain in original packaging.

Iopamiro 200 can interact with certain medications or conditions that affect contrast safety.

Major Interactions (Avoid): - Concurrent nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): increase risk of renal injury – avoid co‑administration if possible. - High‑dose iodine supplements or thyroid hormone therapy: may exacerbate thyroid dysfunction – avoid.

Moderate Interactions (Monitor Closely): - Metformin: risk of lactic acidosis in renal impairment – hold metformin before and after contrast as per guidelines. - Beta‑blockers: may mask contrast‑induced hypertension – monitor blood pressure closely. - Diuretics: can affect fluid balance and renal clearance – assess hydration status.